Vijay Kedia Bets on India’s Infrastructure, Pharma, and PSU Sectors with ₹289 Cr Investment

Vijay Kedia, a renowned investor, has placed a significant bet on India’s growth by investing ₹289 crore in three key sectors: infrastructure, pharmaceuticals, and public sector units (PSUs). Kedia views the recent market dip as a short-term, fear-driven correction rather than a reflection of the country’s robust economic fundamentals. He encourages long-term investors to remain patient and use these market dips as opportunities for accumulation.

Kedia’s investment strategy is rooted in the belief that strong government spending, ongoing development projects, and India’s global leadership in generics and healthcare demand will drive long-term growth. He is particularly bullish on infrastructure, PSU banks, and pharmaceuticals, while avoiding the IT sector due to its limited near-term growth potential.

Sector Overview

Infrastructure Kedia sees significant potential in the infrastructure sector, driven by substantial government capital expenditure (capex) and ongoing development projects. The sector is poised to benefit from India’s rapid urbanization and the need for modern infrastructure to support economic growth.

One of the companies Kedia has invested in is Om Infra Ltd . Founded in 1971, Om Infra Ltd specializes in providing solutions for hydro-mechanical equipment for hydropower and irrigation projects, end-to-end solutions for water connectivity, and infrastructure development. With a market capitalization of ₹808 crore, the company’s shares closed at ₹83.98 per share, down by 0.56% from its previous close. Kedia holds a 2.5% stake (worth ₹21.2 crore) in the company, which has delivered strong profitability metrics with a 4.41% ROCE and 3.34% ROE.

Another key investment in the infrastructure sector is Patel Engineering Ltd . This company is engaged in the construction of dams, bridges, tunnels, roads, and other heavy civil engineering works. With a market capitalization of ₹2,471 crore, the shares of Patel Engineering Ltd closed at ₹24.91 per share, up by 0.93% from its previous close. Kedia holds a 1.0% stake (worth ₹24.4 crore) in the company, which has delivered impressive profitability metrics with a 15.4% ROCE and 10.4% ROE.

Pharmaceuticals The pharmaceutical sector is another area where Kedia sees immense potential, driven by India’s global leadership in generics and the growing demand for healthcare services. Neuland Laboratories Ltd is a leading Indian publicly listed Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad. Founded in 1984, the company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for the global pharmaceutical and biotechnology industries. With a market capitalization of ₹15,401 crore, the shares of Neuland Laboratories Ltd closed at ₹12,004.75 per share, down by 0.74% from its previous close. Kedia holds a 1.0% stake (worth ₹159.5 crore) in the company, which has delivered strong profitability metrics with an 18.7% ROCE and 14.8% ROE.

Public Sector Units (PSUs) Kedia is also bullish on PSU banks, which are expected to benefit from the government’s focus on infrastructure development and economic reforms. Advait Energy Transitions Limited (formerly known as Advait Infratech Limited) is a global leader in end-to-end solutions for power transmission, substations, and telecommunication infrastructure. Founded in 2009 and headquartered in Gujarat, the company has a market capitalization of ₹1,630 crore. The shares of Advait Energy Transitions Limited closed at ₹1,645.45 per share, up by 4.58% from its previous close. Kedia holds a 1.1% stake (worth ₹19.3 crore) in the company, which has delivered strong profitability metrics with a 26.9% ROCE and 22.5% ROE.

Healthcare In the healthcare sector, Yatharth Hospital & Trauma Care Services Ltd is a prominent North Indian healthcare provider operating a network of multi-specialty hospitals in Delhi NCR (Noida, Greater Noida) and Madhya Pradesh (Orchha), with recent expansions in Faridabad. With a market capitalization of ₹6,176 crore, the shares of Yatharth Hospital & Trauma Care Services Ltd closed at ₹641 per share, down by 1.38% from its previous close. Kedia holds a 1% stake (worth ₹63.3 crore) in the company, which has delivered strong profitability metrics with a 14% ROCE and 10.4% ROE.

Conclusion Vijay Kedia’s investment strategy reflects his confidence in India’s economic growth potential, particularly in the infrastructure, pharmaceuticals, and PSU sectors. Despite short-term market volatility, Kedia’s long-term outlook remains optimistic, and he encourages investors to use market dips as opportunities to accumulate high-potential stocks.